![A doctor and patient with the Pfizer logo](https://media.marketrealist.com/brand-img/Efc7GN96j/640x335/pfizer-global-blood-therapeutics-deal-1659978662807.jpg?position=top 640w)
Pfizer to Acquire Global Blood Therapeutics, Achieves Long-Time Goal
Pfizer is acquiring Global Blood Therapeutics in a deal valued at $5.4 billion, which helps Pfizer realize its long-time goal of having a sickle-cell disease portfolio.
The latest news in the healthcare sector including biotech and telehealth.